Related scientific articles (all)

Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trial. (Springerplus)

Authors : Cortés J, Rugo HS, Twelves C, Awada A, Perez EA, Im SA, Zhao C, Hoch U, Tomkinson D, Buchanan J, Tagliaferri M, Hannah A, OShaughnessy J
Year : 2016
Journal : Springerplus
Volume : 5
Pages : 1033

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).

Authors : De Grève J, van Meerbeeck J, Vansteenkiste JF, Decoster L, Meert AP, Vuylsteke P, Focan C, Canon JL, Humblet Y, Berchem G, Colinet B, Galdermans D, Bosquée L, Vermeij J, Dewaele A, Geers C, Schallier D, Teugels E
Year : 2016
Journal : PLoS One
Volume : 11
Pages : e0147599

Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'

Authors : Goldrat O, Demeestere I, Azim HA
Year : 2016
Journal : Eur J Cancer
Volume : 54
Pages : 165-6

Biomarkers for adverse events associated with immune checkpoint inhibitors.

Authors : Kourie HR, Paesmans M, Klastersky J
Year : 2016
Journal : Biomark Med
Volume : 10
Pages : 1029-31

Ex vivo detection of tumoral lymph nodes of colorectal origin with fluorescence imaging after intraoperative intravenous injection of indocyanine green.

Authors : Liberale G, Gomez Galdon M, Moreau M, Vankerckhove S, El Nakadi I, Larsimont D, Donckier V, Bourgeois P
Year : 2016
Journal : J Surg Oncol
Volume : 114(3)
Pages : 348-53

L'euthanasie et la gestion de fin de vie: un débat éthique permanent.

Authors : Berghmans T
Year : 2016
Journal : Rev Med Brux
Volume : 37(2)
Pages : 69

Adapting the robotic platform to small operating theaters: our experience with the side-docking technique for robotic-assisted laparoscopic prostatectomy.

Authors : Albisinni S, Aoun F, Le Dinh D, Limani K, Hawaux E, Peltier A, Van Velthoven R
Year : 2016
Journal : Surg Endosc
Volume : 30(10)
Pages : 4464-8

Diagnosis of congenital von Willebrand disease during a preoperative assessment in a multiple myeloma patient without bleeding history.

Authors : El Ouaaliti M, Li R, Gobin D, Bron D, Cantinieaux B
Year : 2016
Journal : Clin Case Rep
Volume : 4
Pages : 703-6

Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a cross-sectional study.

Authors : Libois A, Feoli F, Nkuize M, Delforge M, Konopnicki D, Clumeck N, De Wit S
Year : 2016
Journal : Sex Transm Infect
Volume : 22
Pages : 1-10

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU.

Authors : Destrebecq V, Ameye L, Berghmans T, Paesmans M, Sculier JP, Meert AP
Year : 2016
Journal : Front Med (Lausanne)
Volume : 3
Pages : 50

GLI inhibitor GANT61 kills melanoma cells and acts in synergy with obatoclax.

Authors : Vlckova K, Reda J, Ondrusova L, Krayem M, Ghanem G, Vachtenheim J
Year : 2016
Journal : Int J Oncol
Volume : 49
Pages : 953-60

Rare side-effects of checkpoint inhibitors.

Authors : Kourie HR, Awada G, Awada A
Year : 2016
Journal : Curr Opin Oncol
Volume : 28
Pages : 295-305

Dispositifs intra-utérins au lévonorgestrel et risque de cancer du sein ?

Authors : Sculier JP
Year : 2016
Journal : Minerva.ebm
Volume : -
Pages : -

The potential of mesenchymal stromal cells in immunotherapy.

Authors : Fayyad-Kazan M, Fayyad-Kazan H, Lagneaux L, Najar M
Year : 2016
Journal : Immunotherapy
Volume : 8
Pages : 839-42

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.

Authors : Lambertini M, Pinto AC, Ameye L, Jongen L, Del Mastro L, Puglisi F, Poggio F, Bonotto M, Floris G, Van Asten K, Wildiers H, Neven P, de Azambuja E, Paesmans M, Azim HA Jr
Year : 2016
Journal : Br J Cancer
Volume : 115(12)
Pages : 1471-78

Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.

Authors : Gil T, Sideris S, Aoun F, Van Velthoven R, Sirtaine N, Paesmans M, Ameye L, Awada A, Devriendt D, Peltier A
Year : 2016
Journal : Mol Clin Oncol
Volume : 5
Pages : 258-264

Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?

Authors : Tabchi S, El Rassy E, Khazaka A, El Karak F, Kourie HR, Chebib R, Assi T, Ghor M, Naamani L, Richa S, Ghosn M, Kattan J
Year : 2016
Journal : Qual Life Res
Volume : 25
Pages : 1597-604

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.

Authors : Bottai G, Raschioni C, Losurdo A, Di Tommaso L, Tinterri C, Torrisi R, Reis-Filho JS, Roncalli M, Sotiriou C, Santoro A, Mantovani A, Loi S, Santarpia L
Year : 2016
Journal : Breast Cancer Res
Volume : 18
Pages : 121

Les patients rapportent-ils mieux les effets toxiques subjectifs de la chimiothérapie anticancéreuse que les médecins ?

Authors : Sculier JP
Year : 2016
Journal : Minerva.ebm
Volume : -
Pages : -

Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer.

Authors : Twelves C, Awada A, Cortes J, Yelle L, Velikova G, Olivo MS, Song J, Dutcus CE, Kaufman PA
Year : 2016
Journal : Breast Cancer (Auckl)
Volume : 10
Pages : 77-84